STE - STERIS plc
NEXT EARNINGS:
May 20, 2026
EPS Est: $2.85
|
Rev Est: $1.6B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$256.67
DETAILS
HIGH:
$265.00
LOW:
$245.00
MEDIAN:
$260.00
CONSENSUS:
$256.67
UPSIDE:
4.02%
Market Cap:
24.22B
Volume:
875,719
Avg Volume:
680,378
52 Week Range:
204.9-269.44
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.04
Last Dividend:
$2.46
Exchange:
NYSE
Country:
IE
Employees:
18,000
IPO Date:
1992-06-01
EPS (TTM):
6.24
P/E Ratio:
36.35
Revenue (TTM):
5.46B
Total Assets:
10.15B
Total Debt:
2.20B
Cash & Equiv:
171.70M
Rev Growth (5Y):
12.5%
EPS Growth (5Y):
5.3%
FCF Growth (5Y):
15.7%
ROCE:
9.7%
Debt/Equity:
0.33
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $2.53 | $2.53 | 0.0% | $1.5B | $1.6B | -6.2% |
| 2025-11-05 | $2.47 | $2.35 | +5.1% | $1.5B | $1.4B | +2.0% |
| 2025-08-06 | $2.34 | $2.26 | +3.5% | $1.4B | $1.4B | +2.1% |
| 2025-05-14 | $2.74 | $2.60 | +5.4% | $1.5B | $1.5B | +0.8% |
| 2025-02-05 | $2.32 | $2.33 | -0.4% | $1.4B | $1.4B | -0.8% |
| 2024-11-06 | $2.14 | $2.12 | +0.9% | $1.3B | $1.3B | -0.1% |
| 2024-08-06 | $2.03 | $1.98 | +2.5% | $1.3B | $1.3B | +0.6% |
| 2024-05-08 | $2.41 | $2.35 | +2.6% | $1.4B | $1.4B | +0.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.46B | 5.14B | 4.54B | 4.22B | 3.11B | 3.03B | 2.78B | 2.62B | 2.61B | 2.24B | 1.85B | 1.62B |
| Net Income | 614.64M | 378.24M | 107.03M | 243.89M | 397.40M | 407.66M | 304.05M | 290.92M | 109.97M | 110.76M | 135.06M | 129.44M |
| EPS | 6.24 | 3.83 | 1.07 | 2.50 | 4.66 | 4.81 | 3.59 | 3.42 | 1.29 | 1.57 | 2.27 | 2.20 |
| Total Assets | 10.15B | 11.06B | 10.82B | 11.42B | 6.57B | 5.44B | 5.07B | 5.20B | 4.92B | 5.35B | 2.10B | 1.89B |
| Total Debt | 2.20B | 3.38B | 3.25B | 3.28B | 1.80B | 1.28B | 1.18B | 1.32B | 1.48B | 1.57B | 621.08M | 493.48M |
| Cash & Equivalents | 171.70M | 207.02M | 208.36M | 348.32M | 220.53M | 319.58M | 220.63M | 201.53M | 282.92M | 248.84M | 167.69M | 152.80M |
| Operating Cash Flow | 1.15B | 973.27M | 756.95M | 684.81M | 689.64M | 590.56M | 539.50M | 457.63M | 424.09M | 254.68M | 246.04M | 209.63M |
| Free Cash Flow | 778.00M | 612.95M | 394.98M | 397.25M | 450.38M | 376.04M | 349.79M | 292.18M | 251.19M | 128.27M | 160.78M | 123.26M |
| FCF per Share | 7.89 | 6.20 | 3.96 | 4.07 | 5.29 | 4.44 | 4.14 | 3.44 | 2.94 | 1.81 | 2.71 | 2.09 |
| Book Value | 6.60B | 6.30B | 6.08B | 6.53B | 3.88B | 3.41B | 3.18B | 3.21B | 2.80B | 3.02B | 1.07B | 1.04B |
| Cash & ST Investments | 171.70M | 207.02M | 208.36M | 348.32M | 220.53M | 319.58M | 220.63M | 201.53M | 282.92M | 248.84M | 167.69M | 152.80M |
| ROC Equity | 0.09 | 0.06 | 0.02 | 0.04 | 0.10 | 0.12 | 0.10 | 0.09 | 0.04 | 0.04 | 0.13 | 0.12 |